| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |